n1,n1-Dimethylcyclopentane-1,3-diamine, 95%, 1g

N-METHOXY-N-METHYL-6-(TRIFLUOROMETHYL)NICOTINAMIDE, 95.0%, 250mg

N-(3-AMINOCYCLOBUTYL)ACETAMIDE HCL, 95.0%, 100mg

Methyl 2-aminooxazole-4-carboxylate, 95.0%, 100g

GC-Kapillarsäule ROTI®Cap-FFAP, 25 m, 0.32 mm, 0.25 µm, polar, 1 Stück

{4-[6-chloro-4-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}(phenyl)methanone, 95.0%, 5g

(2S,4R)-Boc-4-(2-naphthyloxy)pyrrolidine-2-carboxylic acid, 97.0%, 250mg

N2,N2-Diethyl-1,3,5-triazine-2,4,6-triamine, 98%, 5g

(2E)-1-cyclopropyl-3-(dimethylamino)-2-propen-1-one, 95.0%, 250mg

Buparvaquone, 97.0%, 5g

Methyl 1H-imidazole-2-carboxylate, 96.0%, 5g

2-Aminoethyl dihydrogen phosphate, 95.0%, 25g

2-Amino-4,5-diphenyl-furan-3-carbonitrile, 98.0%, 10g